I have written in the past about how the share price of a company often moulds the market’s perception of the underlying business. For microcaps,

During the last 18 months, one of the ASX’s toughest sectors has been micro-cap technology. These businesses usually feature everything the market has hated; they

During a once-in-a-century global pandemic perhaps counterintuitively one of the most affected sectors was the medical device manufacturers. Weighed down by restricted access to customers,

In a world of earnings uncertainty, particularly for businesses who benefited from a pull forward of demand during Covid, investors are pivoting to “recovery” stocks

What is the equivalent of uncovering a buried treasure on the ASX? How about a SaaS business growing sales nearly 100% while trading on a

Since November last year when accelerated vaccine approvals gave the world a clear path out of the COVID pandemic, investors have constantly been searching for